Remy
Administrator
Based on some recent reports and this article, I decided to give daily glatiramer (Copaxone) injections a try.
There is also some evidence it elevates immunoglobulins, specifically subclasses 1 and 3, which I am low in and may also inhibit microglial activation.
I started last week and will post anything I notice one way or another here as time goes on!
A restoration of interleukin 10 production by peripheral B cells was observed in patients undergoing glatiramer acetate therapy as well as a significant reduction of interleukin 6 production in a subset of patients who received therapy for less than 32 months. Furthermore, proliferation in response to high-dose Cluster of Differentiation 40 Ligand (CD40L) was altered and immunoglobulin production was elevated in in vitro–activated B cells obtained from patients who received glatiramer acetate.
Conclusions and Relevance
Glatiramer acetate therapy remodels the composition of the B-cell compartment and influences cytokine secretion and immunoglobulin production. These data suggest that glatiramer acetate therapy affects several aspects of dysregulated B-cell function in MS that may contribute to the therapeutic mechanisms of glatiramer acetate.
There is also some evidence it elevates immunoglobulins, specifically subclasses 1 and 3, which I am low in and may also inhibit microglial activation.
I started last week and will post anything I notice one way or another here as time goes on!